What is the share price of Dr. Agarwal's Health Care Limited (AGARWALEYE) today?
The share price of AGARWALEYE as on 6th August 2026 is ₹532.30. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Dr. Agarwal's Health Care Limited (AGARWALEYE) share?
The past returns of Dr. Agarwal's Health Care Limited (AGARWALEYE) share are- Past 1 week: 8.63%
- Past 1 month: 9.00%
- Past 3 months: 16.16%
- Past 6 months: 18.25%
- Past 1 year: 19.11%
- Past 3 years: N/A%
- Past 5 years: 32.53%
What are the peers or stocks similar to Dr. Agarwal's Health Care Limited (AGARWALEYE)?
The peers or stocks similar to Dr. Agarwal's Health Care Limited (AGARWALEYE) include:What is the market cap of Dr. Agarwal's Health Care Limited (AGARWALEYE) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Dr. Agarwal's Health Care Limited (AGARWALEYE) is ₹16518.65 Cr as of 6th August 2026.What is the 52 week high and low of Dr. Agarwal's Health Care Limited (AGARWALEYE) share?
The 52-week high of Dr. Agarwal's Health Care Limited (AGARWALEYE) is ₹568 and the 52-week low is ₹401.What is the PE and PB ratio of Dr. Agarwal's Health Care Limited (AGARWALEYE) stock?
The P/E (price-to-earnings) ratio of Dr. Agarwal's Health Care Limited (AGARWALEYE) is 124.02. The P/B (price-to-book) ratio is 8.57.Which sector does Dr. Agarwal's Health Care Limited (AGARWALEYE) belong to?
Dr. Agarwal's Health Care Limited (AGARWALEYE) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.How to buy Dr. Agarwal's Health Care Limited (AGARWALEYE) shares?
You can directly buy Dr. Agarwal's Health Care Limited (AGARWALEYE) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Dr. Agarwal's Health Care Limited
AGARWALEYE Share Price
NSE₹532.302.16% (+11.25)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
AGARWALEYE Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
AGARWALEYE Performance & Key Metrics
AGARWALEYE Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 111.33 | 8.57 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 45.38 | 5.86 | 0.51% |
100%
Analysts have suggested that investors can buy this stock
from 5 analysts
Price Upside
Earnings Growth
Rev. Growth
AGARWALEYE Company Profile
Dr. Agarwal's Health Care Ltd operates eye care hospitals and provides a comprehensive range of eye care services, including surgeries, consultations, and optical products.
APOLLOHOSP
PE Ratio
65.98
65.98
1Y Return
24.83%
24.83%
Buy Reco %
86.67
86.67
MAXHEALTH
PE Ratio
72.87
72.87
1Y Return
15.63%
15.63%
Buy Reco %
83.33
83.33
PE Ratio
189.12
189.12
1Y Return
41.41%
41.41%
Buy Reco %
100.00
100.00
FORTIS
PE Ratio
67.03
67.03
1Y Return
7.21%
7.21%
Buy Reco %
85.00
85.00
PE Ratio
47.98
47.98
1Y Return
6.58%
6.58%
Buy Reco %
85.71
85.71
AGARWALEYE Sentiment Analysis
AGARWALEYE Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
AGARWALEYE Stock Summary · May 2026
Management framed FY26 as a year of strong growth and disciplined profitability, with revenue from operations reaching INR 2,080 crore (up 21.6% YoY) and an Ind AS EBITDA margin of 28.9% underpinning margin resilience. They emphasized rapid network roll‑out and clinical standardization as strategic priorities—19 greenfield facilities were commissioned in Q4, expanding a diversified 269‑facility footprint, while a centralized clinical board and in‑house training pipeline aim to sustain quality and specialty adoption. Management acknowledged tension between accelerated openings and near‑term ramp losses, citing a directional INR 30–40 crore opening‑related drag and cohort losses tied to new Delhi investments. For FY27 they reiterated a target of 60 new facilities (40 surgical centres, 20 clinics), guided capital expenditure of INR 380–400 crore and acquisition cash outflows of roughly INR 60–65 crore, and said margins are expected to remain broadly stable as statutory merger approvals progress toward anticipated year‑end completion.
AGARWALEYE Stock Growth Drivers
AGARWALEYE Stock Growth Drivers
10Record Financial Performance and Margin Expansion
The company delivered a milestone financial year, crossing INR 2,000 crore in revenue and reporting
Scale in Clinical Throughput and Workforce
Operational scale has materially increased: the company served over 30 lakh patients and performed more
AGARWALEYE Stock Challenges
AGARWALEYE Stock Challenges
8Elevated operating costs and margin pressure
The subsidiary and group experienced a material rise in operating expenses that has depressed margins.
Significant unit‑economics losses from recent greenfield openings
New branch cohorts have generated substantial operating losses that materially dragged consolidated profitability. Branches opened
AGARWALEYE Forecast
AGARWALEYE Forecasts
Price
Revenue
Earnings
AGARWALEYE Share Price Forecast
AGARWALEYE Share Price Forecast
2026
Current
₹532.30
Baseline
Forecast for Aug 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹532.30
Baseline
Forecast for Aug 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
AGARWALEYE Company Revenue Forecast
AGARWALEYE Company Revenue Forecast
2026
Current
₹2.13
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
2026
Current
₹2.13
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
AGARWALEYE Stock EPS (Earnings Per Share) Forecast
AGARWALEYE Stock EPS (Earnings Per Share) Forecast
2026
Current
₹4.21
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹4.21
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
AGARWALEYE
AGARWALEYE
Income
Balance Sheet
Cash Flow
Quarterly Normal View
AGARWALEYE Income Statement
AGARWALEYE Income Statement
Quarterly Normal View
| Quarter | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | jun 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 369.07 | 409.49 | 428.45 | 443.43 | 475.65 | 500.81 | 506.62 | 540.40 | 578.02 | 620.43 | ||||||||||
Operating & Other expenses | 240.81 | 299.87 | 309.60 | 315.91 | 331.73 | 359.56 | 362.55 | 385.76 | 402.64 | 443.61 | ||||||||||
EBITDA | 128.26 | 109.62 | 118.85 | 127.52 | 143.92 | 141.25 | 144.07 | 154.64 | 175.38 | 176.82 | ||||||||||
| Depreciation/Amortization | 46.70 | 55.51 | 57.18 | 58.18 | 60.39 | 62.95 | 67.86 | 68.75 | 76.68 | 78.31 | ||||||||||
| PBIT | 81.56 | 54.11 | 61.67 | 69.34 | 83.53 | 78.30 | 76.21 | 85.89 | 98.70 | 98.51 | ||||||||||
| Interest & Other Items | 27.39 | 27.03 | 28.40 | 28.35 | 25.01 | 24.70 | 22.55 | 21.13 | 22.08 | 23.37 | ||||||||||
| PBT | 54.17 | 27.08 | 33.27 | 40.99 | 58.52 | 53.60 | 53.66 | 64.76 | 76.62 | 75.14 | ||||||||||
| Taxes & Other Items | 15.42 | 15.10 | 16.69 | 18.65 | 25.95 | 23.55 | 23.97 | 31.02 | 36.91 | 29.91 | ||||||||||
| Net Income | 38.75 | 11.98 | 16.58 | 22.34 | 32.57 | 30.05 | 29.69 | 33.74 | 39.71 | 45.23 | ||||||||||
| EPS | 1.39 | 0.43 | 0.45 | 0.73 | 1.04 | 0.95 | 0.94 | 1.07 | 1.25 | 1.43 |
AGARWALEYE Company Updates
FY 2027FY 2027
Investor Presentation
Aug 4PDF
FY 2026FY 2026
Investor Presentation
May 21PDF
Feb 3PDF
Oct 31PDF
Aug 12PDF
AGARWALEYE Stock Peers
AGARWALEYE Past Performance & Peer Comparison
AGARWALEYE Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareHospitals & Diagnostic Centres
Compare valuation on Screener
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Dr. Agarwal's Health Care Limited | 124.02 | 8.57 | — |
| Apollo Hospitals Enterprise Limited | 65.98 | 12.84 | 0.22% |
| Max Healthcare Institute Limited | 72.87 | 9.78 | 0.19% |
| Aster DM Quality Care Limited | 189.12 | 20.10 | 0.20% |
AGARWALEYE Stock Price Comparison
Compare AGARWALEYE with any stock or ETFCompare AGARWALEYE with any stock or ETF
AGARWALEYE
AGARWALEYE Holdings
AGARWALEYE Shareholdings
AGARWALEYE Promoter Holdings Trend
AGARWALEYE Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
AGARWALEYE Institutional Holdings Trend
AGARWALEYE Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
AGARWALEYE Shareholding Pattern
AGARWALEYE Shareholding Pattern
AGARWALEYE Shareholding History
AGARWALEYE Shareholding History
Foreign Institutions
Mutual Funds Invested in AGARWALEYE
Mutual Funds Invested in AGARWALEYE
No mutual funds holding trends are available
Top 5 Mutual Funds holding Dr. Agarwal's Health Care Limited
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 1.2849% | Percentage of the fund’s portfolio invested in the stock 2.96% | Change in the portfolio weight of the stock over the last 3 months -0.35% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 5/65 (-2) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 1.2543% | Percentage of the fund’s portfolio invested in the stock 1.55% | Change in the portfolio weight of the stock over the last 3 months -0.20% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 50/72 (-3) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.6520% | Percentage of the fund’s portfolio invested in the stock 0.78% | Change in the portfolio weight of the stock over the last 3 months -0.14% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 34/50 (-1) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing AGARWALEYE stock
smallcases containing AGARWALEYE stock
Looks like this stock is not in any smallcase yet.
AGARWALEYE Events
AGARWALEYE Events
AGARWALEYE Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
AGARWALEYE has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
AGARWALEYE Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
AGARWALEYE has not given any dividends in last 5 years
AGARWALEYE Dividends
AGARWALEYE Dividends
Hmm, looks like data is unavailable here. Please come back after some timeAGARWALEYE Stock News & Opinions
AGARWALEYE Stock News & Opinions
Articles & Videos
Earnings
Earnings
Dr Agarwals Health Care Ltd consolidated sales up 8.85% on year in Q2FY2026, net profit improved by 10.13%Dr Agarwals Health Care Ltd share price inched up 0.97% to Rs 483.75 after the company's net profit expanded by 10.13% to Rs 55.02 crore, while revenue from operations slightly gained 8.85% to Rs 614.02 crore in Q2FY26 over Q1FY26. The market capitalization of Hospital industry group stocks on BSE stood at Rs 5.05 lakh crore, easing 4.07%. It has eased by 0.51% over last one week and jumped by 15.67% in last one month while the market capitalization of Dr Agarwals Health Care Ltd has softened by 1.71% and 5.61% in the same period respectively. Profit before tax (PBT) of Dr Agarwals Health Care Ltd stood at Rs 75.14 crore in Q2 FY26, expanding by 40.19% year-on-year, and declining 1.93% quarter-on-quarter. EBITDA came in at Rs 164 crore, rallying 43.27% YoY and climbing 10.15% sequentially. Total expenses saw a slight increase of 8.89% to Rs 521.92 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 0.32 crore, witnessing a sharp rise of 33.33% YoY, while employee benefits expense was at Rs 121.04 crore, jumping 16.62% YoY. For the TTM ended FY26, revenue from operations witnessed a strong growth of 28.44% to Rs 1711.0 crore, while net profit registered a growth of 16.09% to Rs 110.34 crore, compared to previous TTM. EBITDA jumped by 37733% to Rs 410.36 crore, and PBT improved 13.72% to Rs 159.85 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 360.33 crore in FY26, as against Rs 345.96 crore in FY25. Dr Agarwals Health Care Ltd advanced by 5.53% in last one year, significantly outperforming the benchmark BSE Sensex which has softened by 2.94% during the same period.
2 days agoCapital Market - Live
Corporate
Corporate
Dr Agarwals Health Care to conduct board meetingDr Agarwals Health Care will hold a meeting of the Board of Directors of the Company on 4 August 2026.
1 week agoCapital Market - Live
Corporate
Corporate
Dr Agarwal's Health Care to conduct board meetingDr Agarwal's Health Care will hold a meeting of the Board of Directors of the Company on 4 August 2026.
1 week agoCapital Market - Live
Corporate
Corporate
Dr Agarwals Health Care allots 43,155 equity shares under ESOSDr Agarwals Health Care has allotted 43,155 equity shares under ESOS on 09 July 2026. Consequently, the paid up equity share capital has increased to 31,70,26,183 equity shares of Re 1 each.
4 weeks agoCapital Market - Live
Corporate
Corporate
Dr Agarwal's Health Care to conduct EGMDr Agarwal's Health Care announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 2 July 2026.
2 months agoCapital Market - Live
Corporate
Corporate
Dr Agarwals Health Care to conduct EGMDr Agarwals Health Care announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 2 July 2026.
2 months agoCapital Market - Live
Earnings
Earnings
Dr Agarwal's Health Care consolidated net profit rises 21.92% in the March 2026 quarterNet profit of Dr Agarwal's Health Care rose 21.92% to Rs 39.71 crore in the quarter ended March 2026 as against Rs 32.57 crore during the previous quarter ended March 2025. Sales rose 22.57% to Rs 564.11 crore in the quarter ended March 2026 as against Rs 460.22 crore during the previous quarter ended March 2025. For the full year,net profit rose 59.59% to Rs 133.19 crore in the year ended March 2026 as against Rs 83.46 crore during the previous year ended March 2025. Sales rose 21.57% to Rs 2080.08 crore in the year ended March 2026 as against Rs 1711.00 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales564.11460.22 23 2080.081711.00 22 OPM %28.6228.46 -27.3826.67 - PBDT151.97121.41 25 523.55393.61 33 PBT75.2961.02 23 247.31162.87 52 NP39.7132.57 22 133.1983.46 60 Powered by Capital Market - Live
2 months agoCapital Market - Live
Corporate
Corporate
Dr Agarwal's Health Care to declare Quarterly ResultsDr Agarwal's Health Care will hold a meeting of the Board of Directors of the Company on 21 May 2026.
2 months agoCapital Market - Live
Corporate
Corporate
Dr Agarwals Health Care to declare Quarterly ResultsDr Agarwals Health Care will hold a meeting of the Board of Directors of the Company on 21 May 2026.
2 months agoCapital Market - Live
Corporate
Corporate
Dr Agarwals Health Care allots 1.50 lakh equity shares under ESOSDr Agarwals Health Care has allotted 1,50,282 equity shares under ESOS on 08 April 2026. With this allotment, the paid up equity share capital has increased to Rs 31,69,57,788 consisting of 31,69,57,778 equity shares of Re 1 each.
3 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 34.83%, vs industry avg of 16.34%
Over the last 5 years, market share increased from 1.13% to 2.31%